相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Food effect on the pharmacokinetics of entecavir from dispersible tablets following oral administration in healthy Chinese volunteers
Qing-Hua Zhang et al.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH (2011)
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
S. J. Patterson et al.
GUT (2011)
Entecavir Treatment for Chronic Hepatitis B: Adaptation Is Not Needed for the Majority of Naive Patients with a Partial Virological Response
Roeland Zoutendijk et al.
HEPATOLOGY (2011)
Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
Watcharasak Chotiyaputta et al.
JOURNAL OF HEPATOLOGY (2011)
Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses
Gloria Woo et al.
GASTROENTEROLOGY (2010)
Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues
Florian van Boemmel et al.
HEPATOLOGY (2010)
Antiviral Resistance and Hepatitis B Therapy
Marc G. Ghany et al.
HEPATOLOGY (2009)
Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients
Yue Han et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
Stefan Zeuzem et al.
JOURNAL OF HEPATOLOGY (2009)
Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides
M. H. Nguyen et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir
Wilhelmus F. Leemans et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks
Morris Sherman et al.
HEPATOLOGY (2008)
Pre-existing antiviral resistance mutations among treatment-naive HBV patients can be detected by a sensitive line probe assay
S. K. Fung et al.
JOURNAL OF HEPATOLOGY (2008)
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response
Carl J. Baldick et al.
JOURNAL OF HEPATOLOGY (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B
Robert G. Gish et al.
GASTROENTEROLOGY (2007)
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient
Stephanie Villet et al.
JOURNAL OF HEPATOLOGY (2007)
Entecavir pharmacokinetics, safety, and tolerability after multiple ascending doses in healthy subjects
Jing-He Yan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
Florian van Boemmel et al.
HEPATOLOGY (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
A dose-ranging study of the efficacy and tolerability of entecavir in lamivudine-refractory chronic hepatitis B patients
TT Chang et al.
GASTROENTEROLOGY (2005)
Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature
H Mommeja-Marin et al.
HEPATOLOGY (2003)
分享论文
